NCT03216330View on ClinicalTrials.gov

Dyspareunia and Central Sensitization

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

July 19, 2017

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2019

Conditions
EndometriosisCentral SensitisationDyspareunia
Interventions
OTHER

No Intervention

There is no treatment intervention. We are assigning measurement tools such as the Electronic Thimble Algometer for QST and questionnaires to both groups.

Trial Locations (1)

V6H2N9

BC Children's and Women's Hospital, Vancouver

All Listed Sponsors
lead

BC Women's Hospital & Health Centre

OTHER

NCT03216330 - Dyspareunia and Central Sensitization | Biotech Hunter | Biotech Hunter